Scribe Therapeutics Inc. Common Stock (SCTX) Stock
Key stats
- Market cap
- $319.19M
- Price / Earnings ratio
- -15.1x
- EPS (TTM)
- -$1.52
- Volume
- Loading
- 52-week high
- $39.60
- 52-week low
- $13.50
Source: third-party data provider, as of November 13, 2026
Compare with SCTX
Recent news

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY
Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY
SCTX

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms
Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms
SCTX

Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
SCTX
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 44.82
- MACD 12/26/9
- -1.24
- EMA 9 of MACD
- -1.55
- MACD histogram
- 0.31
- SMA 50
- $21.69
- Price below SMA 50
- EMA 50
- $20.19
- Price below EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY
Cathie Wood-Led Ark Loads Up On GOOG, AMD, NVDA And Biotech Stocks — But Sells CRWV, AVGO, LLY
SCTX

Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms
Cathie Wood-Led Ark Invest Sells PLTR, GOOG, SHOP Stocks — But Loads Up On PACB, FRNM And Other Biotech Firms
SCTX

Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
SCTX
News tone: automated (AI) classification of the article's content, not a price prediction.
About Scribe Therapeutics Inc. Common Stock
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Benjamin L. Oakes Ph.D. | Co-Founder, President, CEO & Chairman | 1989 |
| Mr. David L. Parrot M.B.A. | CFO & Treasurer | 1969 |
| Dr. Svetlana Lucas Ph.D. | Chief Business Officer | 1972 |
| Dr. Jennifer A. Doudna Ph.D. | Co-Founder & Scientific Advisor | 1964 |
| Mr. Brett T. Staahl Ph.D. | Co-Founder & VP of External Innovation | — |
| Mr. David F. Savage Ph.D. | Co-Founder & Scientific Advisor | — |
| Mr. Richard Hector J.D., Ph.D. | Head of Intellectual Property | — |
| Ms. Chitra Sharma M.S. | Senior Vice President of Development | — |
| Mr. Sunny Mok M.B.A., Ph.D. | Senior Vice President of Operations | — |
| Stephen V. Thau | Secretary | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 44.82
- MACD 12/26/9
- -1.24
- EMA 9 of MACD
- -1.55
- MACD histogram
- 0.31
- SMA 50
- $21.69
- Price below SMA 50
- EMA 50
- $20.19
- Price below EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $37.00
- Average
- $51.75
- High
- $60.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.0 | +46.5 | -36.5 | -10.2 | +11.7 |



